Afterward, each woman self-administered a single-blind, placebo dose in a clinical setting, supervised by research staff, followed by a one-week monitoring period
Suspected adverse effects from any medicine or unlicensed compound should be reported to the MHRA via the Yellow Card scheme
Preisig M, Fenton BT, Matthey ML, Berney A, Ferrero F (1999)
CRF ligands display distinct affinity to CRF receptors with CRF binding preferentially to CRF 1 and with lesser affinity to CRF 2 (Hillhouse and Grammatopoulos, 2006), while Ucn 1 displays equal high affinity to both CRF 1 and CRF 2 and Ucn 2 and 3 are selective CRF 2 agonists (Grace et al., 2007)
(4) alpha-2-agonists, beta-blockers, and neuroleptics may be used in association when BDZs do not completely resolve specific persisting symptoms of AWS